Eacho P I, Weiner M
Drug Metab Dispos. 1980 Nov-Dec;8(6):385-9.
The metabolism of p-nitroanisole and aniline was studied in isolated hepatocytes of male and female rats rendered diabetic with streptozotocin. In cells of male diabetic rats the production of the oxidized metabolites of both substrates was decreased relative to cells of control rats. In contrast, enzyme activity toward both substrates was increased when isolated microsomes of diabetic males were studied. Cytochrome P-450 content was increased in hepatocytes and microsomes of these animals. Treatment of diabetic male rats with insulin returned drug disposition and cytochrome P-450 in hepatocytes to control levels. In females, production of oxidized metabolites in hepatocytes as well as mono-oxygenase activities in microsomes were increased by diabetes, whereas cytochrome P-450 levels were not significantly altered in hepatocytes or microsomes. The results indicate that the effect of diabetes on drug metabolism observed in microsomal preparations may not accurately reflect the pattern of drug disposition in the whole cell. The pattern may ultimately be determined by other factors within the hepatocytes which are altered in the diabetic condition. Such factors may be responsible for the sex-dependent effects of streptozotocin diabetes on drug metabolism in rat hepatocytes.
在经链脲佐菌素诱导患糖尿病的雄性和雌性大鼠的离体肝细胞中,对4-硝基苯甲醚和苯胺的代谢进行了研究。在雄性糖尿病大鼠的细胞中,相对于对照大鼠的细胞,两种底物的氧化代谢产物的生成均减少。相反,当研究糖尿病雄性大鼠的离体微粒体时,针对两种底物的酶活性增加。这些动物的肝细胞和微粒体中的细胞色素P-450含量增加。用胰岛素治疗糖尿病雄性大鼠可使肝细胞中的药物处置和细胞色素P-450恢复至对照水平。在雌性大鼠中,糖尿病会增加肝细胞中氧化代谢产物的生成以及微粒体中的单加氧酶活性,而肝细胞或微粒体中的细胞色素P-450水平没有显著变化。结果表明,在微粒体制剂中观察到的糖尿病对药物代谢的影响可能无法准确反映全细胞中的药物处置模式。这种模式最终可能由糖尿病状态下发生改变的肝细胞内的其他因素决定。这些因素可能是链脲佐菌素糖尿病对大鼠肝细胞药物代谢产生性别依赖性影响的原因。